Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reach Separations specializes in chromatography purification services for small molecules, serving pharmaceutical, fine chemical, agrochemical, biotech, and cosmetic sectors, from discovery to manufacturing. They offer analytical and preparative scale purification including SFC and HPLC, and were acquired by CatSci Ltd in 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reach Separations.